Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06262399 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

NCT06262399 · ClinicalTrials.gov record · last posted 2025-11-28

Long-Term Follow-Up (LTFU) of Subjects Treated With NTLA 2002

Name: Long-Term Follow-Up (LTFU) of Subjects Treated With NTLA 2002 — clinical trial record (NCT06262399)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusEnrolling by Invitation

PhaseNot specified

SponsorIntellia Therapeutics

Started2024-04-12

View on ClinicalTrials.gov ↗

from the ClinicalTrials.gov record

This is a follow-up study of subjects who received NTLA-2002 in a previous clinical trial as an observational evaluation of the long-term effects of the investigational therapy.

Amendment record 4 amendments on the ClinicalTrials.gov record

This ClinicalTrials.gov record has been amended 4 times since 2024-02-07; most recent amendment 2025-11-25. DataLookout shows field-level changes from the day a trial enters its daily monitoring; earlier amendments are counted here from the ClinicalTrials.gov version history. See every version on ClinicalTrials.gov ↗

2024-05-22

Status change Not Yet Recruiting→Enrolling by Invitationv1

Trial Details

NCT Number	NCT06262399
Lead Sponsor	Intellia Therapeutics
Conditions	Hereditary Angioedema
Enrollment	100 participants
Start Date	2024-04-12
Primary Completion	2040-04 (estimated)
Study Completion	2040-04 (estimated)
Updated on ClinicalTrials.gov	2025-11-28